ViGenCell Inc. (KOSDAQ:308080)
South Korea · Delayed Price · Currency is KRW 8,680.00
+170.00 (2.00%)
At close: Jan 23, 2026
ViGenCell Market Cap
ViGenCell has a market cap or net worth of 170.96 billion as of January 29, 2026. Its market cap has increased by 255.00% in one year.
Market Cap
170.96B
Enterprise Value
133.67B
Revenue
278.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
8,680.00
Market Cap Chart
Since August 25, 2021, ViGenCell's market cap has decreased from 561.23B to 170.96B, a decrease of -69.54%. That is a compound annual growth rate of -23.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 170.96B | -14.46% |
| Dec 30, 2025 | 199.87B | 315.01% |
| Dec 30, 2024 | 48.16B | -57.05% |
| Dec 28, 2023 | 112.12B | -17.15% |
| Dec 29, 2022 | 135.32B | -61.11% |
| Dec 30, 2021 | 347.95B | -38.00% |
| Aug 25, 2021 | 561.23B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vaxcell-Bio Therapeutics | 225.13B |
| Ensol Biosciences | 208.77B |
| Kangstem Biotech | 198.45B |
| Bio Solution | 192.65B |
| curacle co.,ltd. | 186.56B |
| QuadMedicine | 167.40B |
| TiumBio | 159.56B |
| NovMetaPharma | 156.33B |